InVivoMab anti-mouse VEGFR-2 (Clone: DC101)

Catalog number: BE0060_50mg
Brand: Bio X Cell
Packing: 50 mg
Other sizes: 1 mg
5 mg
25 mg
100 mg
Price: On Request
Expected delivery time: 7 days
Quantity:

Product specifications for - InVivoMab anti-mouse VEGFR-2 (Clone: DC101)

Promotion: 
Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: in vivo blocking of VEGF/VEGFR-2 signaling, in vitro blocking of VEGFR signaling
Host: Rat
Clonality: Monoclonal
Isotype: IgG1
Properties: 
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Scientific information: 
Clone ID: DC101
Related products: 
Related products: Recommended Isotype Control(s): InVivoMab rat IgG1 isotype control (anti-HRP) (BE0088), InVivoMab rat IgG1 isotype control (BE0290)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: DC101; BE0060; BioXCell
Arulanandam R, Batenchuk C, Angarita FA, et al. VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection. Cancer Cell. 2015;28(2):210-24. Read more
Lee HJ, Yoon C, Park DJ, et al. Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature. Int J Radiat Oncol Biol Phys. 2015;91(3):621-30. Read more
Ding X, Lucas T, Marcuzzi GP, Pfister H, Eming SA. Distinct functions of epidermal and myeloid-derived VEGF-A in skin tumorigenesis mediated by HPV8. Cancer Res. 2015;75(2):330-43. Read more
Kizhatil K, Ryan M, Marchant JK, Henrich S, John SW. Schlemm's canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process. PLoS Biol. 2014;12(7):e1001912. Read more
Larrayoz M, Pio R, Pajares MJ, et al. Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype. EMBO Mol Med. 2014;6(4):539-50. Read more
Villalta SA, Lang J, Kubeck S, et al. Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function. Diabetes. 2013;62(8):2870-8. Read more
Chatterjee S, Wang Y, Duncan MK, Naik UP. Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing. PLoS ONE. 2013;8(5):e63674. Read more
Kim YJ, Lee HJ, Kim TM, et al. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α. Int J Cancer. 2013;132(1):29-41. Read more
Kumar V, Scandella E, Danuser R, et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood. 2010;115(23):4725-33. Read more
Kilarski WW, Samolov B, Petersson L, Kvanta A, Gerwins P. Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med. 2009;15(6):657-64. Read more